ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 066

Incidence of Juvenile Idiopathic Arthritis in Chile: Estimates from a National Universal Access Program, 2010-2024

Pia Cuevas and Sara Concha, Pontificia Universidad Católica de Chile

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Quality, Health Services, and Education Research I

Session Time: 6:00PM-7:00PM

Background/Purpose: The incidence of juvenile idiopathic arthritis (JIA) varies widely among countries, and currently, updated data for Latin America and Chile are not available. The purpose of this study was to describe the epidemiological behavior of JIA in Chile.

Methods: A descriptive analytical cross-sectional study was conducted, including all children under 16 years of age diagnosed with JIA between 2010 and 2024, according to the National Registry of Explicit Health Guarantees (GES) a legally-mandated national universal access program for diagnosis and treatment of this condition for the public and private healthcare systems. This registry requires compulsory reporting by law, which guarantees nationwide coverage and reliable data. Overall and annual incidence rates per 100.000 children under 16 years of age were calculated, and trends and differences according to sex, age, and region were evaluated using Poisson and quasi-Poisson regression models.

Results: The overall incidence was 5.17 per 100,000 children under 16 years of age, with a stable annual incidence rate over time. The incidence was consistently higher in females across all age groups and increased progressively with age in both sexes. Furthermore, a higher proportion of cases were diagnosed within the public health system, and a greater concentration was observed in the metropolitan region, where the country’s capital is located.

Conclusion: These data allow us to assess the current burden of juvenile idiopathic arthritis (JIA) and guide a better allocation of resources, promoting timely access to diagnosis and treatment. They also provide relevant epidemiological evidence that contributes to the understanding of the disease both in Latin America and globally.

Incidence in woman and men by age groupSupporting image 1


Disclosures: P. Cuevas: None; S. Concha: None.

To cite this abstract in AMA style:

Cuevas P, Concha S. Incidence of Juvenile Idiopathic Arthritis in Chile: Estimates from a National Universal Access Program, 2010-2024 [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/incidence-of-juvenile-idiopathic-arthritis-in-chile-estimates-from-a-national-universal-access-program-2010-2024/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-juvenile-idiopathic-arthritis-in-chile-estimates-from-a-national-universal-access-program-2010-2024/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology